Microbix Reports Results for Q1 2026
MBX Biosciences, Inc.MBX Biosciences, Inc.(US:MBX) Accessnewswire·2026-02-12 12:20

Core Viewpoint - Microbix Biosystems Inc. reported Q1 revenues of $4.2 million, indicating a recovery in revenue growth following previous client setbacks [1] Financial Performance - The company achieved a revenue growth of 13% compared to Q4 fiscal 2025, demonstrating efforts to rebuild revenues above the breakeven point [1] - The controlled net loss indicates improved financial management and operational efficiency [1]